Head to Head Survey: Haoxi Health Technology (NASDAQ:HAO) vs. Banzai International (NASDAQ:BNZI)

Banzai International (NASDAQ:BNZI) and Haoxi Health Technology (NASDAQ:HAO) are both small-cap business services companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk.

Institutional and Insider Ownership

96.8% of Banzai International shares are held by institutional investors. 2.8% of Banzai International shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Banzai International and Haoxi Health Technology’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Banzai International	-237.54%	-391.73%	-74.14%
Haoxi Health Technology	N/A	N/A	N/A

Earnings and Valuation

This table compares Banzai International and Haoxi Health Technology”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Banzai International	$11.48 million	0.31	-$22.49 million	($110.47)	-0.02
Haoxi Health Technology	$42.68 million	0.00	$3.88 million	N/A	N/A

Haoxi Health Technology has higher revenue and earnings than Banzai International.

Risk and Volatility

Banzai International has a beta of -1.01, meaning that its stock price is 201% less volatile than the S&P 500. Comparatively, Haoxi Health Technology has a beta of -1.46, meaning that its stock price is 246% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current recommendations and price targets for Banzai International and Haoxi Health Technology, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Banzai International	1	0	2	0	2.33
Haoxi Health Technology	1	0	0	0	1.00

Banzai International currently has a consensus target price of $42.00, suggesting a potential upside of 1,635.54%. Given Banzai International’s stronger consensus rating and higher possible upside, equities analysts clearly believe Banzai International is more favorable than Haoxi Health Technology.

Summary

Banzai International beats Haoxi Health Technology on 7 of the 12 factors compared between the two stocks.

About Banzai International

Banzai International, Inc., a marketing technology company, provides data-driven marketing and sales solutions for various businesses in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Its products include Demio, a browser-based webinar platform with data and marketing features designed to help businesses engage with their audience through live events and on-demand, interactive video content; Boost, a software-as-a-service (SaaS) solution for social sharing by event registrants; and Reach, a SaaS and managed service to increase registration and attendance of marketing events. The company serves healthcare, financial services, e-commerce, technology, media, and other industries. Banzai International, Inc. was founded in 2015 and is based in Bainbridge Island, Washington.

About Haoxi Health Technology

Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. It serves advertiser client base primarily in the healthcare industry. The company was founded in 2018 and is based in Beijing, China.